Amundi Luxembourg SA News - PRAS

Merck to Share New Research and Host Community-Focused Symposia at AIDS 2024

Symposia will highlight work to overcome HIV-related stigma and discuss the evolving state of HIV treatment and prevention Merck (NYSE: MRK...

Merck Completes Acquisition of EyeBio

Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret™, a novel late-phase candidate for diabetic macular edema...

Merck Animal Health Completes Acquisition of Elanco’s Aqua Business

Acquisition delivers industry-leading portfolio, scientific and research capabilities, for enhanced customer benefits Merck Animal Health, known...

Elanco Completes Sale of Aqua Business

Elanco Completes Sale of Aqua Business PR Newswire GREENFIELD, Ind., July 9, 2024 Transaction concentrates...

Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Orion Corporation (“Orion”) today announced that notice has been...

Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its second-quarter 2024 sales and earnings conference call...

Merck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH)

If approved by the European Commission, WINREVAIR will be the first activin signaling inhibitor therapy for PAH in Europe, offering a new...

CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults

CAPVAXIVE (V116) recommended for all adults age 65 and older and for adults 19 to 64 with certain risk conditions, and for those over 65...

Interactive Brokers Loses $48 Million on NYSE, Amazon Achieves Historic Market Value, and More News

Interactive Brokers (NASDAQ:IBKR) – Interactive Brokers revealed a loss of $48 million due to an error...

Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer

The letter did not identify any issues with the efficacy or safety data submitted in the application The U.S. Food and Drug Administration (FDA...

USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza

Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease Merck Animal Health, known as...

Fisker Files for Bankruptcy, Chegg Stocks Rise on 23% Workforce Reduction, and More

Fisker (NYSE:FSR) – The American electric vehicle manufacturer filed for bankruptcy last night, aiming...

U.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults

CAPVAXIVE (V116) is specifically designed for adults and covers serotypes responsible for approximately 84% of invasive pneumococcal disease in...

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Carboplatin and Paclitaxel as Treatment for Adult Patients With Primary Advanced or Recurrent Endometrial Carcinoma

KEYTRUDA is now the first and only anti-PD-1 therapy FDA-approved in combination with chemotherapy for adult patients with primary advanced or...

Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Robert M. Davis, chairman and chief executive...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Amundi Luxembourg SA (PRAS)

Professional-Grade Tools, for Individual Investors.

PRAS News

Merck to Share New Research and Host Community-Focused Symposia at AIDS 2024

Merck Completes Acquisition of EyeBio

Merck Animal Health Completes Acquisition of Elanco’s Aqua Business

Elanco Completes Sale of Aqua Business

Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30

Merck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH)

CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults

Interactive Brokers Loses $48 Million on NYSE, Amazon Achieves Historic Market Value, and More News

Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer

USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza

Fisker Files for Bankruptcy, Chegg Stocks Rise on 23% Workforce Reduction, and More

U.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Carboplatin and Paclitaxel as Treatment for Adult Patients With Primary Advanced or Recurrent Endometrial Carcinoma

Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

PRAS Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Amundi Luxembourg SA (PRAS) News

Amundi Luxembourg SA (PRAS)

Professional-Grade Tools, for Individual Investors.

PRAS News

Merck to Share New Research and Host Community-Focused Symposia at AIDS 2024

Merck Completes Acquisition of EyeBio

Merck Animal Health Completes Acquisition of Elanco’s Aqua Business

Elanco Completes Sale of Aqua Business

Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30

Merck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH)

CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults

Interactive Brokers Loses $48 Million on NYSE, Amazon Achieves Historic Market Value, and More News

Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer

USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza

Fisker Files for Bankruptcy, Chegg Stocks Rise on 23% Workforce Reduction, and More

U.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Carboplatin and Paclitaxel as Treatment for Adult Patients With Primary Advanced or Recurrent Endometrial Carcinoma

Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

PRAS Discussion

Your Recent History